Skip to main content

Table 3 Factors associated with cognitive impairment among COVID-19 survivors

From: Cognitive after-effects and associated correlates among post-illness COVID-19 survivors: a cross-sectional study, Egypt

Variable Total MoCA score t P-value
≥ 26 (n = 41) < 26 (n = 44)
Mean ± SD Mean ± SD
Age 32.07 ± 8.11 39.57 ± 9.15 − 3.99 < 0.001
  No % No % χ2  
Gender
 Female 32 78.0 37 84.1 0.51 0.476
 Male 9 22.0 7 15.9
Marital status
 Married 34 82.9 41 93.2 2.15 0.143
 Not married 7 17.1 3 6.8
Residence
 Rural 23 56.1 32 72.7 2.57 0.109
 Urban 18 48.2 12 27.3
Level of education
 Low-to-moderate 17 41.5 36 81.8 14.72 < 0.001
 High 24 58.5 8 18.2
Occupation
 Skilled 39 95.1 38 86.4 2.20 0.334
 Employee 2 4.9 5 11.4
 Unemployed 0 0.0 1 2.3
Hx of psychiatric illnesses
 Yes 2 4.9 5 11.4 1.18 0.277
 No 39 95.1 39 88.6
Hx of medical illnesses
 Yes 8 19.5 11 25.0 0.37 0.544
 No 33 80.5 33 75.0
COVID-19 symptom severity
 Mild 21 51.2 19 43.2 0.55 0.458
 Moderate-to-severe 20 48.8 25 56.8
Medications received during COVID-19 infection
 Antibiotics 36 97.3 38 92.7 0.85 0.356
 Anticoagulants 22 59.5 27 65.9 0.34 0.560
 Antimalarial 17 45.9 20 48.8 0.06 0.802
 Iverizine 28 75.7 25 61.0 1.93 0.165
 Steroids 21 56.8 24 58.5 0.03 0.874
  Mean ± SD Mean ± SD MWU  
Home isolation (days) 9.80 ± 9.08 9.70 ± 10.20 − 0.38 0.418
Hospital isolation (days) 5.76 ± 8.71 7.20 ± 9.38 − 0.81 0.707
HADS scoring
 Depression 7.22 ± 4.56 9.02 ± 3.61 − 2.00 0.045
 Anxiety 7.34 ± 4.65 9.07 ± 3.61 − 1.80 0.072
  1. Bold text indicates statistical significance, where P value < 0.05